CLINICAL RESEARCH IN ASIA PACIFIC
WHY ASIA PACIFIC?
For US-based and international sponsors, ClinActis leverages its deep expertise in APAC to deliver faster, more cost-effective clinical trials in key emerging markets.
The Ideal Destination for Clinical Research
The Asia Pacific region is experiencing rapid growth in drug development and clinical research, establishing itself as the ideal destination for US and international sponsors. This growth is fuelled by a diverse patient population, improving infrastructure, and supportive regulatory changes, making clinical research in Asia highly attractive to sponsors looking for efficient and cost-effective solutions. ... see more
Faster Patient Recruitment and Retention
Asia is rapidly emerging as a preferred location for global clinical trials, thanks to its favorable research environment. The region’s large and diverse patient population and fewer competing trials enable faster patient recruitment and better patient retention for clinical studies. ...see more
Streamlined Regulatory and Ethics Processes
The Asia Pacific (APAC) region offers increasingly streamlined regulatory approvals and ethics committee reviews, with clear guidelines and reduced timelines that ensure efficient and compliant trial execution. This can be especially beneficial for US and international sponsors that want to leverage the cost and time-saving benefits of conducting clinical trials in APAC for their clinical development programs. ...see more
Global Standards in Clinical Trials
The Asia Pacific (APAC) region offers a clinical trial environment that adheres to global standards, specifically International Council for Harmonisation (ICH) and Good Clinical Practice (GCP) guidelines. Most APAC countries follow these standards, ensuring that regulatory submissions and approvals meet the highest quality and safety requirements. ...see more
World-Class Clinical Infrastructure
For overseas sponsors including those from the US, the Asia Pacific region offers world-class clinical infrastructure, supported by top-tier facilities and substantial government backing that enhances clinical trial capabilities. ...see more
Cost Advantages
Discover significant savings in drug development by expanding your clinical trials to the Asia Pacific (APAC) region. Conducting clinical trials in APAC offers unparalleled cost advantages for US and international sponsors, thanks to lower salaries, reduced operational expenses, and access to diverse patient pools. ...see more
Data Acceptance by Major Regulatory Bodies
Clinical data from the APAC region is increasingly being accepted by major regulatory bodies like the U.S. Food and Drug Administration (FDA) and European Medicines Association (EMA), showcasing the region's credibility and adherence to global standards. ...see more
Huge Drug Development Market Size
The APAC pharmaceutical market is thriving, projected to reach $1.6 trillion by 2025, offering immense opportunities for drug development and market expansion. ...see more
Improving Intellectual Property Protection
Clinical data from the APAC region is increasingly being accepted by major regulatory bodies like the U.S. Food and Drug Administration (FDA) and European Medicines Association (EMA), showcasing the region's credibility and adherence to global standards. ...see more